ClinicalTrials.gg
RecruitingNCT06234124Updated May 11, 2026

Characterization and Clinical Trial of a Variable Friction Shoe

An interventional study of Variable Friction Shoe Training and Ankle Foot Orthosis (AFO) Training in Stroke, sponsored by Shirley Ryan AbilityLab. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Stroke by Shirley Ryan AbilityLab — 12 open to participants now, 20 under way, none of them phase 3. Stroke · Shirley Ryan AbilityLab.

Planned enrollment
18th of 55
50 · median 30
Started
2024
with 6 others
No phase
49 of 64
10 open now
Primary completion
2027-01
later than 12 of 19 live
Registered
57th of 64
by date

Among the 64 studies in Stroke by Shirley Ryan AbilityLab, this one is the 18th largest by planned enrollment of the 55 interventional ones that give a count, is one of 7 that started in 2024, is one of 49 with no phase, reaches primary completion later than 12 of the 19 other live ones, and was the 57th registered.

Stroke

8,281 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

12 of the 64 studies in Stroke by Shirley Ryan AbilityLab are open now, in 1 country. Recruiting first, the newest first:

6 more — sign in →

By country, each count listing its studies:

All 12 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Stroke by Shirley Ryan AbilityLab, or all of them as a file.
02

Study summary

More than one million Americans present with foot drop after stroke. As the aging population grows in the United States and across the world, incidence of stroke will grow as age is a key risk factor, thus there will be a need for low-cost, easy-to-use, and scalable solutions to administer proper therapy to promote recovery. This study will evaluate a Variable Friction shoe (VF shoe), a new low-cost medical device, for foot drop in an at-home setting.

Read the detailed description

The investigators propose an alternative strategy that addresses the hazard of tripping even while allowing full volitional control of the ankle: an inexpensive Variable Friction (VF) shoe. Its outsole is high-friction during the stance phase of gait and low friction during swing; further, it produces a "click" when a scuff occurs.

The investigator's central hypothesis is that allowing volitional motion of the ankle while mitigating the hazard of tripping coupled with gait-phased auditory biofeedback will result in improved gait for subjects with drop foot. Specifically, the investigators hypothesize that the VF shoe will show significantly greater therapeutic effects than an AFO, yet maintain the desirable orthotic effect of the AFO. The study is arranged in two Aims.

Exploratory Aim: Identify a systematic, methodical approach to device fitting, in-clinic and at-home training with the VF shoe and optimization of collecting outcome measures as assessments. For example, up to 10 participants will be enrolled for up to 8 visits over 12 weeks to determine the optimal data collection methods, fitting and training of use of VF shoes, and order of assessments, etc.

Specific Aim 1: Characterize the scuff-force reduction of the VF shoe over the lifetime of use. Critical to understanding the effects of the VF shoe is a characterization of the level of scuff-force reduction.

Specific Aim 2: Evaluate the effects of the VF shoe on gait in individuals with chronic stroke and drop foot. During each 12-week phase of an AB-BA clinical trial, participants will walk for at least 30-45 minutes per day for at least 5 days per week at home.

03

Conditions studied

  • Stroke

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. At least 3 months poststroke
  2. Age 18 or older
  3. Possess a prescribed AFO or be a potential candidate for use of an AFO
  4. Can ambulate at least 10m with or without an assistive device such as a cane or walker
  5. Medically stable as determined by physician medical clearance
  6. No expected change in medications for at least 3 months
  7. Adequate stability at the ankle during stance
  8. Ability to hear clicking noise made by the VF shoe
  9. Physician approval
  10. Ability to give
  11. Able to sit unsupported and be able to follow a three-step command
  12. No unhealed/unresolved orthopedic injury to either upper or lower extremity and no history of severe back pain
  13. English speaking
  14. Willing to follow an exercise program with both devices for at least 30 minutes per day, at least 5 days per week for the full length of the program (6 months)

Exclusion criteria

Exclusion Criteria:

  1. History of falling more than once a week prior to the stroke
  2. Gait speed: self-selected velocity (SSV) greater than 1.2 m/s
  3. Inability to operate in the devices safely and no caregiver assistance available
  4. Morbid obesity ( >40 kg/m2)
  5. Preexisting conditions such as serious cardiac conditions, myocardial infarction, congestive heart failure, demand pacemaker, seizures, excessive dysesthetic pain, and severe lower extremity pathology that would interfere with fit or use of the shoe.
  6. Severe deficits in cognition or communication
  7. Pregnant women (status determined by self-reporting).
  8. Co-morbidity that interferes with the study (e.g. significant arthritis or joint problems, history of back injury, neuromuscular disorders, epilepsy, etc.).
  9. Severe Osteoporosis (status determined by self-reporting).
  10. Prisoners
  11. Not currently receiving botox to the lower extremities.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Arm AB: Variable Friction Shoe Training, AFO Training

    Baseline (T0), 12 weeks Variable Friction Shoe Training, Follow-up (T1), 2-week washout, Follow-up (T2), 12 weeks AFO Training, Follow-up (T3)

    Device: Variable Friction Shoe Training · Device: Ankle Foot Orthosis (AFO) Training

  • Experimental
    Arm BA: Ankle Foot Orthosis (AFO) Training, Variable Friction Shoe Training

    Baseline (T0), 12 weeks AFO Training, Follow-up (T1), 2-week washout, Follow-up (T2), 12 weeks Variable Friction Shoe Training, Follow-up (T3)

    Device: Variable Friction Shoe Training · Device: Ankle Foot Orthosis (AFO) Training

Interventions

  • DeviceVariable Friction Shoe Training

    The experimental group (A) will be given a pair of VF shoes and instructed to use shoes on both feet. This group will be instructed to walk on hard surfaces to engage auditory feedback of the VF shoes. This group group will be monitored daily using actigraphy and will receive weekly check-up telephone calls by a member of the research team to record number of steps, walking time, a scale for self-identified effort and perceived safety levels.

  • DeviceAnkle Foot Orthosis (AFO) Training

    The control group (B) will be provided an AFO to use on the paretic limb. This group will be instructed to walk on hard surfaces. This group group will be monitored daily using actigraphy and will receive weekly check-up telephone calls by a member of the research team to record number of steps, walking time, a scale for self-identified effort and perceived safety levels.

06

What researchers measure

Primary outcomes

  1. Walking Speed (Device Off)

    10 meter walk test (meters/second)

    Time frame: 26 weeks

Secondary outcomes

  1. Berg Balance Scale

    14 item objective measure designed to assess static balance and fall risk in adult populations. Items assessed include siting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed. Each item is scored 0 to 4 points for a maximum of 56 points.

    Time frame: 26 weeks

  2. 6 Minute Walk Test

    The 6MWT measures the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary.

    Time frame: 26 weeks

  3. Stroke Impact Scale

    The SIS is a validated measure of the impact of stroke on overall physical and cognitive function. This 59-item patient-based questionnaire assesses eight domains of stroke recovery: strength, mobility, communication, emotion, memory and thinking, participation, activities of daily living/instrumental activities of daily living (ADL/IADL) and hand function. An additional question requires the patient to rate their stroke recovery on a scale from 0 to 100. This measure instructs subjects to answer the question based on the period of time twofour weeks prior to the questionnaire

    Time frame: 26 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Burridge JH, Taylor PN, Hagan SA, Wood DE, Swain ID. The effects of common peroneal stimulation on the effort and speed of walking: a randomized controlled trial with chronic hemiplegic patients. Clin Rehabil. 1997 Aug;11(3):201-10. doi: 10.1177/026921559701100303. PubMed 9360032 ↗
  • Bulley C, Mercer TH, Hooper JE, Cowan P, Scott S, van der Linden ML. Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis. Disabil Rehabil Assist Technol. 2015 Nov;10(6):458-467. doi: 10.3109/17483107.2014.913713. Epub 2014 May 6. PubMed 24796365 ↗
  • Lee YS, Wang PY. Foot drop caused by a brain tumor: a case report. Acta Neurol Taiwan. 2009 Jun;18(2):130-1. PubMed 19673367 ↗
  • Stewart JD. Foot drop: where, why and what to do? Pract Neurol. 2008 Jun;8(3):158-69. doi: 10.1136/jnnp.2008.149393. PubMed 18502948 ↗
  • Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31. No abstract available. PubMed 29386200 ↗
  • Lawrence ES, Coshall C, Dundas R, Stewart J, Rudd AG, Howard R, Wolfe CD. Estimates of the prevalence of acute stroke impairments and disability in a multiethnic population. Stroke. 2001 Jun;32(6):1279-84. doi: 10.1161/01.str.32.6.1279. PubMed 11387487 ↗
  • Barker WH, Mullooly JP. Stroke in a defined elderly population, 1967-1985. A less lethal and disabling but no less common disease. Stroke. 1997 Feb;28(2):284-90. doi: 10.1161/01.str.28.2.284. PubMed 9040676 ↗
  • Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence of spasticity post stroke. Clin Rehabil. 2002 Aug;16(5):515-22. doi: 10.1191/0269215502cr512oa. PubMed 12194622 ↗
  • S. J. Olney and C. Richards, "Hemiparetic gait following stroke. Part I: Characteristics," Gait Posture, vol. 4, no. 2, pp. 136-148, 1996.
  • Hyndman D, Ashburn A, Stack E. Fall events among people with stroke living in the community: circumstances of falls and characteristics of fallers. Arch Phys Med Rehabil. 2002 Feb;83(2):165-70. doi: 10.1053/apmr.2002.28030. PubMed 11833018 ↗
  • Bethoux F, Rogers HL, Nolan KJ, Abrams GM, Annaswamy TM, Brandstater M, Browne B, Burnfield JM, Feng W, Freed MJ, Geis C, Greenberg J, Gudesblatt M, Ikramuddin F, Jayaraman A, Kautz SA, Lutsep HL, Madhavan S, Meilahn J, Pease WS, Rao N, Seetharama S, Sethi P, Turk MA, Wallis RA, Kufta C. The effects of peroneal nerve functional electrical stimulation versus ankle-foot orthosis in patients with chronic stroke: a randomized controlled trial. Neurorehabil Neural Repair. 2014 Sep;28(7):688-97. doi: 10.1177/1545968314521007. Epub 2014 Feb 13. PubMed 24526708 ↗
  • Everaert DG, Stein RB, Abrams GM, Dromerick AW, Francisco GE, Hafner BJ, Huskey TN, Munin MC, Nolan KJ, Kufta CV. Effect of a foot-drop stimulator and ankle-foot orthosis on walking performance after stroke: a multicenter randomized controlled trial. Neurorehabil Neural Repair. 2013 Sep;27(7):579-91. doi: 10.1177/1545968313481278. Epub 2013 Apr 4. PubMed 23558080 ↗
  • Bethoux F, Rogers HL, Nolan KJ, Abrams GM, Annaswamy T, Brandstater M, Browne B, Burnfield JM, Feng W, Freed MJ, Geis C, Greenberg J, Gudesblatt M, Ikramuddin F, Jayaraman A, Kautz SA, Lutsep HL, Madhavan S, Meilahn J, Pease WS, Rao N, Seetharama S, Sethi P, Turk MA, Wallis RA, Kufta C. Long-Term Follow-up to a Randomized Controlled Trial Comparing Peroneal Nerve Functional Electrical Stimulation to an Ankle Foot Orthosis for Patients With Chronic Stroke. Neurorehabil Neural Repair. 2015 Nov-Dec;29(10):911-22. doi: 10.1177/1545968315570325. Epub 2015 Feb 4. PubMed 25653225 ↗
  • Ferreira LA, Neto HP, Grecco LA, Christovao TC, Duarte NA, Lazzari RD, Galli M, Oliveira CS. Effect of Ankle-foot Orthosis on Gait Velocity and Cadence of Stroke Patients: A Systematic Review. J Phys Ther Sci. 2013 Nov;25(11):1503-8. doi: 10.1589/jpts.25.1503. Epub 2013 Dec 11. PubMed 24396220 ↗
  • Hesse S, Uhlenbrock D, Sarkodie-Gyan T. Gait pattern of severely disabled hemiparetic subjects on a new controlled gait trainer as compared to assisted treadmill walking with partial body weight support. Clin Rehabil. 1999 Oct;13(5):401-10. doi: 10.1191/026921599673896297. PubMed 10498347 ↗
  • Abe H, Michimata A, Sugawara K, Sugaya N, Izumi S. Improving gait stability in stroke hemiplegic patients with a plastic ankle-foot orthosis. Tohoku J Exp Med. 2009 Jul;218(3):193-9. doi: 10.1620/tjem.218.193. PubMed 19561389 ↗
  • Esquenazi A, Ofluoglu D, Hirai B, Kim S. The effect of an ankle-foot orthosis on temporal spatial parameters and asymmetry of gait in hemiparetic patients. PM R. 2009 Nov;1(11):1014-8. doi: 10.1016/j.pmrj.2009.09.012. PubMed 19942187 ↗
  • Kottink AI, Hermens HJ, Nene AV, Tenniglo MJ, Groothuis-Oudshoorn CG, IJzerman MJ. Therapeutic effect of an implantable peroneal nerve stimulator in subjects with chronic stroke and footdrop: a randomized controlled trial. Phys Ther. 2008 Apr;88(4):437-48. doi: 10.2522/ptj.20070035. Epub 2008 Jan 24. PubMed 18218825 ↗
  • Kluding PM, Dunning K, O'Dell MW, Wu SS, Ginosian J, Feld J, McBride K. Foot drop stimulation versus ankle foot orthosis after stroke: 30-week outcomes. Stroke. 2013 Jun;44(6):1660-9. doi: 10.1161/STROKEAHA.111.000334. Epub 2013 May 2. PubMed 23640829 ↗
  • Nudo RJ, Milliken GW. Reorganization of movement representations in primary motor cortex following focal ischemic infarcts in adult squirrel monkeys. J Neurophysiol. 1996 May;75(5):2144-9. doi: 10.1152/jn.1996.75.5.2144. PubMed 8734610 ↗
  • Stein RB, Everaert DG, Thompson AK, Chong SL, Whittaker M, Robertson J, Kuether G. Long-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disorders. Neurorehabil Neural Repair. 2010 Feb;24(2):152-67. doi: 10.1177/1545968309347681. Epub 2009 Oct 21. PubMed 19846759 ↗
  • Hausdorff JM, Ring H. Effects of a new radio frequency-controlled neuroprosthesis on gait symmetry and rhythmicity in patients with chronic hemiparesis. Am J Phys Med Rehabil. 2008 Jan;87(1):4-13. doi: 10.1097/PHM.0b013e31815e6680. PubMed 18158427 ↗
  • Stein RB, Chong S, Everaert DG, Rolf R, Thompson AK, Whittaker M, Robertson J, Fung J, Preuss R, Momose K, Ihashi K. A multicenter trial of a footdrop stimulator controlled by a tilt sensor. Neurorehabil Neural Repair. 2006 Sep;20(3):371-9. doi: 10.1177/1545968306289292. PubMed 16885423 ↗
  • Taylor PN, Burridge JH, Dunkerley AL, Wood DE, Norton JA, Singleton C, Swain ID. Clinical use of the Odstock dropped foot stimulator: its effect on the speed and effort of walking. Arch Phys Med Rehabil. 1999 Dec;80(12):1577-83. doi: 10.1016/s0003-9993(99)90333-7. PubMed 10597809 ↗
  • Ring H, Treger I, Gruendlinger L, Hausdorff JM. Neuroprosthesis for footdrop compared with an ankle-foot orthosis: effects on postural control during walking. J Stroke Cerebrovasc Dis. 2009 Jan;18(1):41-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.08.006. PubMed 19110144 ↗
  • Laufer Y, Ring H, Sprecher E, Hausdorff JM. Gait in individuals with chronic hemiparesis: one-year follow-up of the effects of a neuroprosthesis that ameliorates foot drop. J Neurol Phys Ther. 2009 Jun;33(2):104-10. doi: 10.1097/NPT.0b013e3181a33624. PubMed 19556919 ↗
  • Everaert DG, Thompson AK, Chong SL, Stein RB. Does functional electrical stimulation for foot drop strengthen corticospinal connections? Neurorehabil Neural Repair. 2010 Feb;24(2):168-77. doi: 10.1177/1545968309349939. Epub 2009 Oct 27. PubMed 19861590 ↗
  • Robbins SM, Houghton PE, Woodbury MG, Brown JL. The therapeutic effect of functional and transcutaneous electric stimulation on improving gait speed in stroke patients: a meta-analysis. Arch Phys Med Rehabil. 2006 Jun;87(6):853-9. doi: 10.1016/j.apmr.2006.02.026. PubMed 16731222 ↗
  • Kottink AI, Hermens HJ, Nene AV, Tenniglo MJ, van der Aa HE, Buschman HP, Ijzerman MJ. A randomized controlled trial of an implantable 2-channel peroneal nerve stimulator on walking speed and activity in poststroke hemiplegia. Arch Phys Med Rehabil. 2007 Aug;88(8):971-8. doi: 10.1016/j.apmr.2007.05.002. PubMed 17678657 ↗
  • Paci M. Physiotherapy based on the Bobath concept for adults with post-stroke hemiplegia: a review of effectiveness studies. J Rehabil Med. 2003 Jan;35(1):2-7. doi: 10.1080/16501970306106. PubMed 12610841 ↗
  • Edgerton VR, Tillakaratne NJ, Bigbee AJ, de Leon RD, Roy RR. Plasticity of the spinal neural circuitry after injury. Annu Rev Neurosci. 2004;27:145-67. doi: 10.1146/annurev.neuro.27.070203.144308. PubMed 15217329 ↗
  • Pohl M, Mehrholz J, Ritschel C, Ruckriem S. Speed-dependent treadmill training in ambulatory hemiparetic stroke patients: a randomized controlled trial. Stroke. 2002 Feb;33(2):553-8. doi: 10.1161/hs0202.102365. PubMed 11823669 ↗
  • Ada L, Dean CM, Hall JM, Bampton J, Crompton S. A treadmill and overground walking program improves walking in persons residing in the community after stroke: a placebo-controlled, randomized trial. Arch Phys Med Rehabil. 2003 Oct;84(10):1486-91. doi: 10.1016/s0003-9993(03)00349-6. PubMed 14586916 ↗
  • Macko RF, Ivey FM, Forrester LW, Hanley D, Sorkin JD, Katzel LI, Silver KH, Goldberg AP. Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: a randomized, controlled trial. Stroke. 2005 Oct;36(10):2206-11. doi: 10.1161/01.STR.0000181076.91805.89. Epub 2005 Sep 8. PubMed 16151035 ↗
  • Werner C, Bardeleben A, Mauritz KH, Kirker S, Hesse S. Treadmill training with partial body weight support and physiotherapy in stroke patients: a preliminary comparison. Eur J Neurol. 2002 Nov;9(6):639-44. doi: 10.1046/j.1468-1331.2002.00492.x. PubMed 12453080 ↗
  • Hornby TG, Campbell DD, Kahn JH, Demott T, Moore JL, Roth HR. Enhanced gait-related improvements after therapist- versus robotic-assisted locomotor training in subjects with chronic stroke: a randomized controlled study. Stroke. 2008 Jun;39(6):1786-92. doi: 10.1161/STROKEAHA.107.504779. Epub 2008 May 8. PubMed 18467648 ↗
  • Colombo G, Joerg M, Schreier R, Dietz V. Treadmill training of paraplegic patients using a robotic orthosis. J Rehabil Res Dev. 2000 Nov-Dec;37(6):693-700. PubMed 11321005 ↗
  • Bruni MF, Melegari C, De Cola MC, Bramanti A, Bramanti P, Calabro RS. What does best evidence tell us about robotic gait rehabilitation in stroke patients: A systematic review and meta-analysis. J Clin Neurosci. 2018 Feb;48:11-17. doi: 10.1016/j.jocn.2017.10.048. Epub 2017 Dec 6. PubMed 29208476 ↗
  • Hidler J, Nichols D, Pelliccio M, Brady K, Campbell DD, Kahn JH, Hornby TG. Multicenter randomized clinical trial evaluating the effectiveness of the Lokomat in subacute stroke. Neurorehabil Neural Repair. 2009 Jan;23(1):5-13. doi: 10.1177/1545968308326632. PubMed 19109447 ↗
  • Lynch D, Ferraro M, Krol J, Trudell CM, Christos P, Volpe BT. Continuous passive motion improves shoulder joint integrity following stroke. Clin Rehabil. 2005 Sep;19(6):594-9. doi: 10.1191/0269215505cr901oa. PubMed 16180594 ↗
  • Lewek MD, Cruz TH, Moore JL, Roth HR, Dhaher YY, Hornby TG. Allowing intralimb kinematic variability during locomotor training poststroke improves kinematic consistency: a subgroup analysis from a randomized clinical trial. Phys Ther. 2009 Aug;89(8):829-39. doi: 10.2522/ptj.20080180. Epub 2009 Jun 11. PubMed 19520734 ↗
  • D.O. Hebb, The Organization of Behavior. New York: Wiley, 1949.
  • Stanton R, Ada L, Dean CM, Preston E. Biofeedback improves performance in lower limb activities more than usual therapy in people following stroke: a systematic review. J Physiother. 2017 Jan;63(1):11-16. doi: 10.1016/j.jphys.2016.11.006. Epub 2016 Nov 25. PubMed 27989731 ↗
  • Sungkarat S, Fisher BE, Kovindha A. Efficacy of an insole shoe wedge and augmented pressure sensor for gait training in individuals with stroke: a randomized controlled trial. Clin Rehabil. 2011 Apr;25(4):360-9. doi: 10.1177/0269215510386125. Epub 2010 Dec 9. PubMed 21148267 ↗
  • Lang CE, Lohse KR, Birkenmeier RL. Dose and timing in neurorehabilitation: prescribing motor therapy after stroke. Curr Opin Neurol. 2015 Dec;28(6):549-55. doi: 10.1097/WCO.0000000000000256. PubMed 26402404 ↗
  • Lang CE, Macdonald JR, Reisman DS, Boyd L, Jacobson Kimberley T, Schindler-Ivens SM, Hornby TG, Ross SA, Scheets PL. Observation of amounts of movement practice provided during stroke rehabilitation. Arch Phys Med Rehabil. 2009 Oct;90(10):1692-8. doi: 10.1016/j.apmr.2009.04.005. PubMed 19801058 ↗
  • T. Susko and H. I. Krebs, "MIT-Skywalker: A novel environment for neural gait rehabilitation," in 5th IEEE RAS/EMBS International Conference on Biomedical Robotics and Biomechatronics, Aug. 2014, pp. 677- 682. doi: 10.1109/BIOROB.2014.6913856.
  • T. G. Susko, "MIT Skywalker : a novel robot for gait rehabilitation of stroke and cerebral palsy patients," Thesis, Massachusetts Institute of Technology, 2015. Accessed: Sep. 26, 2022. [Online]. Available: https://dspace.mit.edu/handle/1721.1/97844
  • T. Susko and H. I. Krebs, "Cycle variance: proposing a novel ensemble-based approach to assess the gait rhythmicity on the MIT-Skywalker," in 2015 IEEE International Conference on Rehabilitation Robotics (ICORR), Aug. 2015, pp. 101-106. doi: 10.1109/ICORR.2015.7281183.
  • Susko T, Swaminathan K, Krebs HI. MIT-Skywalker: A Novel Gait Neurorehabilitation Robot for Stroke and Cerebral Palsy. IEEE Trans Neural Syst Rehabil Eng. 2016 Oct;24(10):1089-1099. doi: 10.1109/TNSRE.2016.2533492. Epub 2016 Feb 25. PubMed 26929056 ↗
  • Wu AR, Kuo AD. Determinants of preferred ground clearance during swing phase of human walking. J Exp Biol. 2016 Oct 1;219(Pt 19):3106-3113. doi: 10.1242/jeb.137356. Epub 2016 Jul 29. PubMed 27473435 ↗
  • Evora A, Sloan E, Castellino S, Hawkes EW, Susko T. Pilot Study of Cadence, a Novel Shoe for Patients with Foot Drop. Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:5291-5296. doi: 10.1109/EMBC.2019.8857096. PubMed 31947051 ↗
  • Hemler SL, Pliner EM, Redfern MS, Haight JM, Beschorner KE. Traction performance across the life of slip-resistant footwear: Preliminary results from a longitudinal study. J Safety Res. 2020 Sep;74:219-225. doi: 10.1016/j.jsr.2020.06.005. Epub 2020 Jul 9. PubMed 32951786 ↗
  • Hemler SL, Pliner EM, Redfern MS, Haight JM, Beschorner KE. Effects of natural shoe wear on traction performance: a longitudinal study. Footwear Sci. 2022;14(1):1-12. doi: 10.1080/19424280.2021.1994022. Epub 2021 Nov 11. PubMed 37701063 ↗
  • J. Perry, Gait Analysis: Normal and Pathological Function. SLACK, 1992.
  • Delp SL, Anderson FC, Arnold AS, Loan P, Habib A, John CT, Guendelman E, Thelen DG. OpenSim: open-source software to create and analyze dynamic simulations of movement. IEEE Trans Biomed Eng. 2007 Nov;54(11):1940-50. doi: 10.1109/TBME.2007.901024. PubMed 18018689 ↗
  • Seth A, Hicks JL, Uchida TK, Habib A, Dembia CL, Dunne JJ, Ong CF, DeMers MS, Rajagopal A, Millard M, Hamner SR, Arnold EM, Yong JR, Lakshmikanth SK, Sherman MA, Ku JP, Delp SL. OpenSim: Simulating musculoskeletal dynamics and neuromuscular control to study human and animal movement. PLoS Comput Biol. 2018 Jul 26;14(7):e1006223. doi: 10.1371/journal.pcbi.1006223. eCollection 2018 Jul. PubMed 30048444 ↗
  • Simpson CS, Welker CG, Uhlrich SD, Sketch SM, Jackson RW, Delp SL, Collins SH, Selinger JC, Hawkes EW. Connecting the legs with a spring improves human running economy. J Exp Biol. 2019 Sep 3;222(Pt 17):jeb202895. doi: 10.1242/jeb.202895. PubMed 31395676 ↗
  • Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011 May 14;377(9778):1693-702. doi: 10.1016/S0140-6736(11)60325-5. PubMed 21571152 ↗
  • Duncan PW, Sullivan KJ, Behrman AL, Azen SP, Wu SS, Nadeau SE, Dobkin BH, Rose DK, Tilson JK, Cen S, Hayden SK; LEAPS Investigative Team. Body-weight-supported treadmill rehabilitation after stroke. N Engl J Med. 2011 May 26;364(21):2026-36. doi: 10.1056/NEJMoa1010790. PubMed 21612471 ↗
  • Rose DK, Nadeau SE, Wu SS, Tilson JK, Dobkin BH, Pei Q, Duncan PW. Locomotor Training and Strength and Balance Exercises for Walking Recovery After Stroke: Response to Number of Training Sessions. Phys Ther. 2017 Nov 1;97(11):1066-1074. doi: 10.1093/ptj/pzx079. PubMed 29077960 ↗
  • Cheng DK, Nelson M, Brooks D, Salbach NM. Validation of stroke-specific protocols for the 10-meter walk test and 6-minute walk test conducted using 15-meter and 30-meter walkways. Top Stroke Rehabil. 2020 May;27(4):251-261. doi: 10.1080/10749357.2019.1691815. Epub 2019 Nov 21. PubMed 31752634 ↗
  • Hiengkaew V, Jitaree K, Chaiyawat P. Minimal detectable changes of the Berg Balance Scale, Fugl-Meyer Assessment Scale, Timed "Up & Go" Test, gait speeds, and 2-minute walk test in individuals with chronic stroke with different degrees of ankle plantarflexor tone. Arch Phys Med Rehabil. 2012 Jul;93(7):1201-8. doi: 10.1016/j.apmr.2012.01.014. Epub 2012 Apr 12. PubMed 22502805 ↗
  • Perry J, Garrett M, Gronley JK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke. 1995 Jun;26(6):982-9. doi: 10.1161/01.str.26.6.982. PubMed 7762050 ↗
  • Schmidt H, Werner C, Bernhardt R, Hesse S, Kruger J. Gait rehabilitation machines based on programmable footplates. J Neuroeng Rehabil. 2007 Feb 9;4:2. doi: 10.1186/1743-0003-4-2. PubMed 17291335 ↗
  • Bohannon RW, Walsh S. Nature, reliability, and predictive value of muscle performance measures in patients with hemiparesis following stroke. Arch Phys Med Rehabil. 1992 Aug;73(8):721-5. PubMed 1642521 ↗
  • Hsu AL, Tang PF, Jan MH. Analysis of impairments influencing gait velocity and asymmetry of hemiplegic patients after mild to moderate stroke. Arch Phys Med Rehabil. 2003 Aug;84(8):1185-93. doi: 10.1016/s0003-9993(03)00030-3. PubMed 12917858 ↗
  • Maeda A, Yuasa T, Nakamura K, Higuchi S, Motohashi Y. Physical performance tests after stroke: reliability and validity. Am J Phys Med Rehabil. 2000 Nov-Dec;79(6):519-25. doi: 10.1097/00002060-200011000-00008. PubMed 11083302 ↗
  • Cunha IT, Lim PA, Henson H, Monga T, Qureshy H, Protas EJ. Performance-based gait tests for acute stroke patients. Am J Phys Med Rehabil. 2002 Nov;81(11):848-56. doi: 10.1097/00002060-200211000-00008. PubMed 12394997 ↗
  • Wolf SL, Catlin PA, Gage K, Gurucharri K, Robertson R, Stephen K. Establishing the reliability and validity of measurements of walking time using the Emory Functional Ambulation Profile. Phys Ther. 1999 Dec;79(12):1122-33. PubMed 10630281 ↗
  • Tyson SF, Kent RM. Effects of an ankle-foot orthosis on balance and walking after stroke: a systematic review and pooled meta-analysis. Arch Phys Med Rehabil. 2013 Jul;94(7):1377-85. doi: 10.1016/j.apmr.2012.12.025. Epub 2013 Feb 12. PubMed 23416220 ↗
  • Mojica JA, Nakamura R, Kobayashi T, Handa T, Morohashi I, Watanabe S. Effect of ankle-foot orthosis (AFO) on body sway and walking capacity of hemiparetic stroke patients. Tohoku J Exp Med. 1988 Dec;156(4):395-401. doi: 10.1620/tjem.156.395. PubMed 3245041 ↗
  • Kobsar D, Osis ST, Boyd JE, Hettinga BA, Ferber R. Wearable sensors to predict improvement following an exercise intervention in patients with knee osteoarthritis. J Neuroeng Rehabil. 2017 Sep 12;14(1):94. doi: 10.1186/s12984-017-0309-z. PubMed 28899433 ↗
  • A. Vehtari, A. Gelman, and J. Gabry, "Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC," Stat. Comput., vol. 27, no. 5, pp. 1413-1432, Sep. 2017, doi: 10.1007/s11222-016- 9696-4.
  • B. Kumari and T. Swarnkar, "Filter versus Wrapper Feature Subset Selection in Large Dimensionality Micro array: A Review."
  • Ranganathan P, Pramesh CS, Aggarwal R. Common pitfalls in statistical analysis: Intention-to-treat versus per-protocol analysis. Perspect Clin Res. 2016 Jul-Sep;7(3):144-6. doi: 10.4103/2229-3485.184823. PubMed 27453832 ↗
  • Sakellaropoulos T, Vougas K, Narang S, Koinis F, Kotsinas A, Polyzos A, Moss TJ, Piha-Paul S, Zhou H, Kardala E, Damianidou E, Alexopoulos LG, Aifantis I, Townsend PA, Panayiotidis MI, Sfikakis P, Bartek J, Fitzgerald RC, Thanos D, Mills Shaw KR, Petty R, Tsirigos A, Gorgoulis VG. A Deep Learning Framework for Predicting Response to Therapy in Cancer. Cell Rep. 2019 Dec 10;29(11):3367-3373.e4. doi: 10.1016/j.celrep.2019.11.017. PubMed 31825821 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Jan 2027, 33 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 33 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2024
First posted
Jan 31, 2024
StartActual
Apr 3, 2024
Primary completionEst.
Jan 2027
CompletionEst.
Jun 2027
Last update
May 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06234124
Responsible party
Arun Jayaraman, PT, PhD (Principle Investigator, Shirley Ryan AbilityLab) — Principal investigator
First posted
Jan 31, 2024
Start date
Apr 3, 2024
Primary completion
Jan 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
May 11, 2026

Study contacts

Joe Harris, DPT
Contact
jharris2@sralab.org
312-238-8425
Jennifer Bartloff, DPT, PhD
Contact
jbartloff@sralab.org
312-238-1562
Arun H Jayaraman, DPT, PhD
principal investigator · Shirley Ryan AbilityLab

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion